Price Chart

Profile

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
URL https://www.fortressbiotech.com
Investor Relations URL https://www.fortressbiotech.com/investors
HQ State/Province Florida
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 18, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
URL https://www.fortressbiotech.com
Investor Relations URL https://www.fortressbiotech.com/investors
HQ State/Province Florida
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 18, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A